Cyramza 100 mg Injection (Ramucirumab 100 mg/10 mL)
Cyramza 100 mg Injection contains ramucirumab 100 mg, a targeted monoclonal antibody used under the supervision of a qualified oncologist for the treatment of certain advanced or metastatic cancers. Cyramza works by targeting VEGFR-2 (vascular endothelial growth factor receptor 2), a pathway involved in the formation of new blood vessels that can support tumor growth.
Cyramza 100 mg is a prescription oncology medicine and is administered by intravenous (IV) infusion by a trained healthcare professional. The recommended dose, treatment schedule, and whether Cyramza is used alone or with other anticancer medicines depend on the patient’s diagnosis, previous treatment, overall health, and the prescribing oncologist’s assessment.
Product Details
Brand: Cyramza
Active Ingredient: Ramucirumab
Strength: 100 mg
Presentation: 100 mg/10 mL injection
Dosage Form: Concentrate for solution for intravenous infusion
Therapeutic Category: Oncology / Antineoplastic
Administration: Intravenous infusion
Prescription: Required
Cyramza 100 mg Uses
Cyramza (ramucirumab) may be prescribed for specific patients with:
- Advanced or metastatic gastric (stomach) cancer or gastroesophageal junction (GEJ) adenocarcinoma
- Certain forms of non-small cell lung cancer (NSCLC)
- Metastatic colorectal cancer
- Selected cases of hepatocellular carcinoma (HCC/liver cancer)
The approved indication and treatment combination vary according to the type and stage of cancer and the patient’s previous treatment history.
Cyramza 100mg (ramucirumab) is a prescription oncology medicine supplied as a 100 mg/10 mL solution for intravenous infusion and used under the supervision of a qualified healthcare professional. Cyramza 100 is a VEGFR2-targeted medicine that may be prescribed as part of treatment for certain advanced or metastatic cancers, depending on the patient’s diagnosis and approved treatment indication. Cyramza should be administered only by appropriately trained medical professionals according to the prescribing information and oncologist’s instructions. For patients and healthcare providers looking for reliable product information, this Cyramza 100mg product page provides details about the formulation, availability, and ordering information. Always consult your treating oncologist before purchasing or using Cyramza.
How Cyramza 100 mg Works
Cyramza contains ramucirumab, a VEGFR-2 antagonist. VEGFR-2 is part of the signaling pathway that promotes angiogenesis, or the formation of new blood vessels.
By blocking VEGFR-2, ramucirumab interferes with this blood-vessel signaling pathway and can help inhibit processes that support tumor growth.
How Cyramza 100 mg Injection Is Given
Cyramza 100 mg Injection is administered intravenously (IV) by a healthcare professional in a hospital, clinic, or appropriate oncology treatment setting.
Do not self-administer Cyramza or change the prescribed dose or treatment schedule. Your oncologist will determine the appropriate regimen based on your cancer type, treatment history, medical condition, and response to therapy.
Cyramza 100mg is a prescription medicine containing ramucirumab, a VEGFR2-targeting monoclonal antibody used in the treatment of certain advanced or metastatic cancers. Cyramza 100 is supplied as a 100 mg/10 mL single-dose vial for intravenous infusion and should be administered by a qualified healthcare professional according to the prescribing information. Depending on the patient’s condition and treatment plan, Cyramza may be used for certain gastric or gastroesophageal junction cancers, non-small cell lung cancer, metastatic colorectal cancer, and hepatocellular carcinoma. Patients should use Cyramza only under the supervision of their oncologist, as treatment, dosage, and administration depend on the specific cancer and individual medical circumstances. For product availability and current pricing of Cyramza 100mg, refer to the product information and consult a healthcare professional before use.
Cyramza 100 mg Side Effects
Possible side effects of Cyramza may include:
- High blood pressure
- Diarrhea
- Headache
- Fatigue
- Protein in the urine
- Bleeding or hemorrhage
- Infusion-related reactions
Cyramza can also cause serious adverse reactions, including severe bleeding, gastrointestinal perforation, impaired wound healing, arterial thromboembolic events, hypertension, and serious infusion-related reactions. Your healthcare team may monitor blood pressure, urine protein, and other relevant parameters during treatment.
Cyramza 100mg (ramucirumab) is a prescription oncology medicine supplied as an intravenous infusion and used under the supervision of a qualified healthcare professional for certain advanced or metastatic cancers. Cyramza is available as a 100 mg/10 mL single-dose vial, and Cyramza 100 is a commonly searched formulation for patients and healthcare providers looking for ramucirumab treatment options. If you are researching Cyramza cost, the final price may vary depending on the supplier, location, availability, and applicable healthcare or pharmacy charges. Cyramza (ramucirumab) is a VEGFR2 antagonist with approved uses that include certain gastric or gastroesophageal junction cancers, metastatic non-small cell lung cancer, metastatic colorectal cancer, and hepatocellular carcinoma in specific patient populations. Cyramza should be administered only according to a qualified physician’s prescription and treatment plan, as it carries important risks including serious bleeding, gastrointestinal perforation, hypertension, infusion-related reactions, and impaired wound healing.
Important Safety Information
Before receiving Cyramza, tell your doctor if you have high blood pressure, bleeding problems, a history of blood clots, liver disease, kidney problems, or a recent or planned surgical procedure.
Cyramza may affect wound healing and may increase the risk of bleeding. Your doctor should also know about all prescription medicines, over-the-counter medicines, vitamins, and supplements you are taking.
Cyramza can cause fetal harm. Women who are pregnant, planning pregnancy, or who could become pregnant should discuss the potential risks with their healthcare professional before treatment.
Cyramza 100 mg Storage
Cyramza 100 mg Injection should be stored under the conditions specified by the manufacturer. In general, the product is refrigerated at 2°C to 8°C and should not be frozen. Proper cold-chain handling is important for maintaining product quality.
Buy Cyramza 100 mg Injection Online
If you are looking for Cyramza 100 mg Injection, Ramucirumab 100 mg/10 mL, or information about Cyramza 100 mg price in India, availability may vary by supplier and batch.
Because Cyramza is a prescription oncology medicine, it should be purchased and used only with a valid prescription and under the supervision of a qualified healthcare professional. Please confirm product availability, batch details, expiry date, storage requirements, and prescription requirements before placing an order.
Cyramza 100 mg Injection should not be purchased or used for self-treatment. Always follow your oncologist’s prescription and medical advice.
FAQ
What is Cyramza 100 mg Injection?
Cyramza 100 mg Injection contains ramucirumab 100 mg/10 mL, a monoclonal antibody used to treat certain advanced or metastatic cancers. It works by blocking VEGFR-2, a protein involved in the formation of new blood vessels that can support tumor growth.
What is Cyramza 100 mg used for?
Cyramza (ramucirumab) may be used for certain patients with gastric or gastroesophageal junction cancer, non-small cell lung cancer, colorectal cancer, and hepatocellular carcinoma, depending on the specific indication and treatment history. It should only be used according to an oncologist's prescription.
What is the active ingredient in Cyramza 100 mg?
The active ingredient in Cyramza 100 mg Injection is ramucirumab 100 mg. The medicine is supplied as a concentrate for intravenous infusion.
How does Cyramza 100 mg work?
Cyramza contains ramucirumab, which binds to and blocks vascular endothelial growth factor receptor 2 (VEGFR-2). This inhibits signaling involved in angiogenesis, the process through which new blood vessels form, potentially limiting blood-vessel support for tumor growth.
How is Cyramza 100 mg Injection administered?
Cyramza is administered as an intravenous (IV) infusion by a qualified healthcare professional. The dose and treatment schedule depend on the patient's cancer type, treatment regimen, medical condition, and response to treatment.
Can Cyramza 100 mg be used during pregnancy?
Cyramza may cause fetal harm. If you are pregnant, planning to become pregnant, or could become pregnant, discuss the potential risks and appropriate precautions with your doctor before receiving treatment.
What precautions should be taken before using Cyramza?
Tell your doctor about any history of high blood pressure, bleeding problems, blood clots, liver or kidney problems, or recent/planned surgery. Also provide your healthcare professional with a complete list of medicines, supplements, and other treatments you are receiving.
